New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - antithymocyte immunoglobulin 25mg (rabbit) - powder for infusion - 25 mg - active: antithymocyte immunoglobulin 25mg (rabbit) excipient: glycine mannitol sodium chloride - thymoglobuline® (rabbit anti - human thymocyte immunoglobulin) is indicated for the prophylaxis of graft rejection in renal transplantation; treatment of steroid - resistant or moderate to severe renal transplant rejection and in the prophylaxis of graft rejection in heart transplantation.

Israel - engelsk - Ministry of Health

glaxo smith kline (israel) ltd - rabies, inactivated, whole virus - powder and solvent for solution for injection - rabies, inactivated, whole virus 2.5 iu/ml - rabies, inactivated, whole virus - rabies, inactivated, whole virus - rabipur is indicated for active immunization against rabies in individuals of all ages.

Israel - engelsk - Ministry of Health

sanofi israel ltd - rabies, inactivated, whole virus - powder and solvent for suspension for injection - rabies, inactivated, whole virus 2.5 iu - rabies, inactivated, whole virus - rabies, inactivated, whole virus - prevention of rabies in children and adults. it can be used before and after exposure, as a primary vaccination or as a booster dose.

Den Europæiske Union - engelsk - EMA (European Medicines Agency)

seqirus s.r.l.  - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza-a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/turkey/turkey/1/05 (h5n1)-like strain.aflunov should be used in accordance with official recommendations.

Den Europæiske Union - engelsk - EMA (European Medicines Agency)

sanofi pasteur s.a. - split influenza virus, inactivated, containing antigen*: a/california/7/2009 (h1n1)v like strain (x-179a)*propagated in eggs. - influenza, human; immunization; disease outbreaks - vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - influenza virus a (h1n1) haemagglutinin 15ug (a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238)); influenza virus a (h3n2) haemagglutinin 15ug (a/thailand/8/2022 (h3n2)-like strain (a/california/122/2022, san-022)); influenza virus b (victoria) haemagglutinin 15ug (b/austria/1359417/2021 - like strain (b/michigan/01/2021, wild type)); influenza virus b (yamagata) haemagglutinin 15ug (b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type)) - suspension for injection - 60 mcg - active: influenza virus a (h1n1) haemagglutinin 15ug (a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238)) influenza virus a (h3n2) haemagglutinin 15ug (a/thailand/8/2022 (h3n2)-like strain (a/california/122/2022, san-022)) influenza virus b (victoria) haemagglutinin 15ug (b/austria/1359417/2021 - like strain (b/michigan/01/2021, wild type)) influenza virus b (yamagata) haemagglutinin 15ug (b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type)) excipient: octoxinol 9 phosphate buffered saline - fluquadri is indicated for active immunisation of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluquadri is indicated for use in adults and children 6 months and older.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 7.5ug (a/michigan/45/2015, x-275); influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 7.5ug (a/singapore/infimh-16-0019/2016, nib-104); influenza virus b/brisbane/60/2008 - like strain 7.5ug (b/brisbane/60/2008 (victoria lineage)); influenza virus b/phuket/3073/2013 - like strain 7.5ug (b/phuket/3073/2013 (yamagata lineage)) - suspension for injection - 30 mcg - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 7.5ug (a/michigan/45/2015, x-275) influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 7.5ug (a/singapore/infimh-16-0019/2016, nib-104) influenza virus b/brisbane/60/2008 - like strain 7.5ug (b/brisbane/60/2008 (victoria lineage)) influenza virus b/phuket/3073/2013 - like strain 7.5ug (b/phuket/3073/2013 (yamagata lineage)) excipient: octoxinol 9 phosphate buffered saline - fluquadri junior is indicated for active immunisation of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluquadri junior is indicated for use in children aged 6 months to 35 months inclusive.

New Zealand - engelsk - Ministry for Primary Industries

zoetis new zealand limited - rabbit calicivirus (rcd) - inactivated - rabbit calicivirus (rcd) - inactivated 0 vaccine - vaccine

USA - engelsk - NLM (National Library of Medicine)

novartis vaccines and diagnostics limited - influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) (unii: 872508x6jg) (influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:5cl7878s2q) - influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated) 15 ug in 0.5 ml

USA - engelsk - NLM (National Library of Medicine)

seqirus inc. - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) (unii: q3p251c5mt) (influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:ld80h821hf) - influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated) 15 ug in 0.5 ml